What is the maximum daily dose of imipramine in adults and what are the signs and management of its toxicity?

Maximum Dose and Toxicity of Imipramine in Adults

The maximum daily dose of imipramine in adults is 300 mg/day for hospitalized patients under close supervision, while outpatients should not exceed 200 mg/day; toxicity manifests primarily as cardiac conduction abnormalities (QRS prolongation, arrhythmias), anticholinergic crisis, seizures, and CNS depression, requiring immediate treatment with sodium bicarbonate for life-threatening cardiotoxicity. 1, 2

Maximum Dosing Guidelines

Hospitalized Patients

• Initial dose: 100 mg/day in divided doses, gradually increased to 200 mg/day as required 1
• Maximum dose: 250–300 mg/day if no response occurs after two weeks 1
• Doses above 300 mg/day are not recommended in the FDA labeling 1

Outpatients

• Initial dose: 75 mg/day, increased to 150 mg/day 1
• Maximum dose: 200 mg/day—dosages over this threshold are explicitly not recommended 1
• Outpatients require lower doses than hospitalized patients due to lack of close supervision 1

Special Populations

• Elderly and adolescent patients: Initial dose 30–40 mg/day; generally should not exceed 100 mg/day 1
• Maintenance therapy: 50–150 mg/day after remission is achieved 1

Critical Dosing Threshold

• Doses exceeding 100 mg/day are associated with increased risk of sudden cardiac death, particularly in patients with pre-existing cardiovascular disease 3
• A dose of 2.5 mg/kg/day should not be exceeded in pediatric patients; ECG changes of unknown significance have been reported at twice this amount 1

Signs of Imipramine Toxicity

Cardiac Toxicity (Most Life-Threatening)

• QRS prolongation (intraventricular conduction delay) is the hallmark finding that typically precedes ventricular arrhythmias 2
• Terminal rightward axis deviation, best appreciated in lead aVR 2
• Ventricular dysrhythmias including ventricular tachycardia and fibrillation 2
• Cardiovascular collapse and cardiogenic shock 2
• Hypotension and bradycardia 2
• Serious dose-related cardiac effects have been firmly established in clinical experience 4

Central Nervous System Toxicity

• Seizures are a prominent feature of sodium channel blocker poisoning 2
• CNS depression, delirium, and altered mental status 2, 4
• Coma in severe cases 4

Anticholinergic Crisis

• Severe dry mouth 3, 5
• Urinary retention 3
• Constipation 3
• Blurred vision 3
• Hyperthermia 6
• Delirium and agitation 6
• These anticholinergic effects are more pronounced with imipramine than with secondary-amine tricyclics like nortriptyline or desipramine 3

Other Manifestations

• Tachycardia (persistent even during maintenance therapy) 5
• Excessive sweating 5
• Neuromuscular rigidity in severe cases 6

Management of Imipramine Toxicity

First-Line Treatment: Sodium Bicarbonate

Sodium bicarbonate is the recommended treatment for life-threatening cardiotoxicity from tricyclic antidepressant poisoning 2

• Administer hypertonic sodium bicarbonate solutions (1000 mEq/L in adults, 500 mEq/L in children) as intravenous boluses 2
• Sodium loading and increasing serum pH (correcting acidemia or inducing alkalemia) each provide benefit, with additive effects when combined 2
• Use sodium bicarbonate to treat hypotension and dysrhythmias specifically 2
• Monitor for characteristic ECG changes (QRS prolongation, rightward axis deviation) which usually precede ventricular dysrhythmias 2

Advanced Supportive Measures

• Extracorporeal life support (VA-ECMO) is reasonable for refractory cardiogenic shock from sodium channel blocker poisoning 2
• Vaughan-Williams class Ib antidysrhythmics (e.g., lidocaine) may be reasonable for life-threatening cardiotoxicity 2
• Intravenous lipid emulsion may be reasonable for life-threatening toxicity refractory to other treatments 2

Seizure Management

• Benzodiazepines (diazepam first-line, or midazolam) have demonstrated efficacy for seizures in poisoning cases 2

Airway Protection

• Early endotracheal intubation should be considered in patients with significant toxicity based on observational data 2

Monitoring Requirements

• Continuous cardiac monitoring with ECG to detect QRS widening and arrhythmias 2, 3
• Serial vital signs including blood pressure and heart rate 2
• Assessment of mental status and neurological function 2, 4

Common Pitfalls and Caveats

Therapeutic Drug Monitoring

• The optimal steady-state plasma concentration range for combined imipramine plus desipramine (its active metabolite) is approximately 175–300 ng/mL 7
• TDM is useful when non-compliance, drug interactions, or lack of clinical response is suspected despite adequate dosing 3
• Consider TDM if no therapeutic effect is observed despite dosing at 2.5 mg/kg/day 3

Hepatotoxicity Risk

• Single daily dosing of 300 mg (6 mg/kg) may be more hazardous to the liver than divided doses, based on a case report showing elevated liver enzymes despite therapeutic plasma concentrations 8
• Monitor liver function if high doses are used 8

Storage and Overdose Prevention

• Store imipramine in a locked location away from children; accidental ingestion can be fatal 3
• Prescribe the smallest feasible quantity to reduce the amount available for potential overdose 3

Drug Interactions

• Avoid combining with other serotonergic medications due to risk of serotonin syndrome 6
• A fatal cardiac arrhythmia was reported in a child receiving dexedrine with imipramine at 6.9 mg/kg/day 3

Suicide Risk Monitoring

• Begin systematic monitoring for suicidal thoughts within 1–2 weeks after starting imipramine 3
• The highest risk for suicide occurs during the first 1–2 months of therapy 3
• Worsening depressive symptoms during this period is a red-flag sign 3